Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

The Oncologist | ResearchHub - ResearchHub

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

ResearchHub

Research, connected

Explore the graph

ResearchGate

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Journal graph

The Oncologist

Oxford University Press (OUP) · ISSN 1083-7159

9

Verified works

0

Citations

—

Access

Researchers publishing here

6 linked researchers

Mustafa Ersoy Tuba Uğur Tuzcu Kadriye Bir Yücel Mustafa Altınbaş Gökşen İnanç İmamoğlu Osman Sütcüoğlu

Research in this journal

Global Disparities in the Availability and Reimbursement of Systemic Therapies for Renal Cell Carcinoma: Results of the International ARON-AID Survey2026 · Yuksel Urun, Kannan Sridharan, Anca Zgura · 0 citations

Baseline 25-Hydroxyvitamin D and Progression-Free Survival in de novo mHSPC: Prognostic Model Development and External Validation2026 · Mustafa Ersoy, Tuba Uğur Tuzcu, Kadriye Bir Yücel · 0 citations

New prognosis indexes specific to Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma combining functional hepatic reserve and tumor burden2026 · Koji Fujita, Rie Yano, Mai Nakahara · 0 citations

Real-World Patient-Reported Outcome Comparing Antibody-Drug Conjugates and Conventional Chemotherapy in Metastatic Breast Cancer2026 · Manuela Milani, Francesco Riccetelli, Carla Strina · 0 citations

Non-Conventional Histologies of Prostate Cancer: From Morphology to Biology-Driven Precision Oncology

2026 · Fabiano Flauto, Giuseppe Neola, Alessia Cimadamore · 0 citations

Distinct sleep and rest-activity profiles according to adjuvant treatment exposure in women treated for breast cancer2026 · Alicia Leclercq, Abderrahmane Rahmani, Baptiste Morel · 0 citations

Re-evaluating the Role of Adjuvant Chemotherapy after Neoadjuvant Therapy in Resected Gastric Cancer2026 · Aravind Sreeram, Celine Yeh, Nicolas Toumbacaris · 0 citations

REVERCE II: A Phase II trial of regorafenib followed by anti-EGFR therapy versus reverse sequencing in refractory metastatic colorectal cancer2026 · Oluseyi B Abidoye, Fang-Shu Ou, Angela Ulrich · 0 citations

Dose Response Relationship of Medical Cannabis and Symptom Control in Patients With Pancreatic Cancer: An Analysis of the CANPAN Trial2026 · Arjun Gupta, Kendall Lin, Ella Chrenka · 0 citations